Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new ...

For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...

Going off antipsychotics can feel like proving something, as well as resolving issues of antipsychotic use. But hear me out ...

Millions of lives—and billions in healthcare costs—are at stake due to one critical but often ignored issue: failure to ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...

Jen Butler, chief commercial officer, Pleio, discusses how personalization, connectivity, technology, and proactive support ...

Program content developed by: William J. Feinberg, RPh, MBA, University of Wyoming School of Pharmacy, Manager of Professional Education Review Programs; President, W-F Professional Associates ...

This year’s campaign, #DontMissaMoment, tackles widespread non-adherence, which leads to worsening health outcomes, unnecessary hospitalisations, and rising healthcare costs. The World Heart ...

Jen Butler, chief commercial officer, Pleio, discusses the effectiveness of peer-to-patient outreach when starting specialty ...

"Medication non-adherence can extend illnesses, trigger chronic disease and mental health flare-ups leading to costly hospitalizations, prolonged treatments, and even death, making it a major ...